share_log

Sight Sciences Up 21%, Insider Buyers Are Up 147%

Sight Sciences Up 21%, Insider Buyers Are Up 147%

Sight Sciences股价上涨21%,内部买家增加了147%。
Simply Wall St ·  07/12 08:43

Sight Sciences, Inc. (NASDAQ:SGHT) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 21% resulting in a US$66m addition to the company's market value. In other words, the original US$2.99m purchase is now worth US$7.41m.

过去12个月内,Sight Sciences, Inc.(NASDAQ:SGHT)内部人员购买的股票获得了丰厚的回报。该股上涨21%,导致公司市值增加了6600万美元。换句话说,原始的299万美元的购买现在价值741万元美元。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

虽然我们绝不建议投资者仅基于公司董事所做的事情来作出决策,但我们认为密切关注内部人士所做的事情是完全合理的。

Sight Sciences Insider Transactions Over The Last Year

过去一年中的 Sight Sciences 内部交易

In the last twelve months, the biggest single purchase by an insider was when Independent Chairman Staffan Encrantz bought US$1.8m worth of shares at a price of US$3.46 per share. We do like to see buying, but this purchase was made at well below the current price of US$7.52. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

过去12个月内,独立董事长Staffan Encrantz的最大单笔购买是以每股3.46美元的价格购买了价值180万美元的股票。我们确实喜欢看到购买,但此次交易的价格远低于当前的7.52美元。虽然这表明内部人士认为该股在较低价格时被低估,但此次交易并没有告诉我们他们对当前价格的看法。

Staffan Encrantz purchased 985.12k shares over the year. The average price per share was US$3.04. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

Staffan Encrantz在一年内购买了985,120股,平均每股价格为3.04美元。您可以在下面的图表中查看公司和个人过去一年的内部交易。点击下面的图表,您可以看到每个内部交易的详细信息!

big
NasdaqGS:SGHT Insider Trading Volume July 12th 2024
NasdaqGS:SGHt Insider Trading Volume 2024年7月12日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

还有很多其他的公司,公司的内部人士正在购买股票。你可能不想错过这个免费的小市值公司的低估列表。

Sight Sciences Insiders Are Selling The Stock

Sight Sciences 内部人士正在卖出股票

Over the last three months, we've seen significant insider selling at Sight Sciences. In total, insiders dumped US$290k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.

过去三个月,我们看到在 Sight Sciences 进行了大量内部人员销售。在那个时候,总计内部人员抛售了29万美元的股票,而我们没有记录到任何购买。总体而言,这使我们有点谨慎,但这并不是一切的终止。

Insider Ownership Of Sight Sciences

Sight Sciences 内部持股

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Sight Sciences insiders own 21% of the company, worth about US$66m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

测试一个公司领导者与其他股东之间的一致性的另一种方法是看他们拥有多少股份。如果内部人员拥有公司中相当数量的股份,则这是一个好迹象。看起来 Sight Sciences 内部人员拥有公司的21%,价值约为6600万美元。这种内部持股水平不错,但还不足以特别出色。它确实表明了相当程度的一致性。

So What Does This Data Suggest About Sight Sciences Insiders?

Sight Sciences 内部人员交易的数据表明了什么?

Insiders sold Sight Sciences shares recently, but they didn't buy any. In contrast, they appear keener if you look at the last twelve months. And insiders do own shares. So we're not overly bothered by recent selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 4 warning signs for Sight Sciences and we suggest you have a look.

内部人员最近出售了 Sight Sciences 股票,但他们没有买入任何股票。相反,如果您看过去的一年,他们似乎更热衷于购买。内部人员确实拥有股份。因此,我们对最近的出售并不过分担心。因此,这些内部交易可以帮助我们建立对该股票的投资信仰,但也值得了解该公司面临的风险。你会很感兴趣知道,我们发现 Sight Sciences 存在4个预警信号,建议您查看。

Of course Sight Sciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

当然,Sight Sciences 可能不是最好的股票购买选择。因此,您可能希望查看这些高质量公司的免费收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

对于本文而言,内部人是指向相关监管机构报告其交易的个人。我们目前仅考虑公开市场交易和直接利益的私人处置,但不包括衍生交易或间接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关注内容?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈? 对内容感到担忧? 请直接与我们联系。 或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发